HSIC

Henry Schein Inc.

Price

$86.23

return (12m)

31.37%

p/e

22.64

p/bv

2.53

DIVIDEND YIELD

0.00%

HSIC price

Henry Schein

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HSIC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-4.92%

3 months

1.51%

1 year

31.37%

2 years

23.49%

5 years

9.57%

10 years

5.34%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals HSIC

Valuation

P/E

22.64

Sector 1.14

Industry 3.38

P/BV

2.53

Sector 1.86

Industry 2.20

P/Revenue (PSR)

0.71

Sector 1.56

Industry 1.80

EV/EBITDA

44.65

Sector -48.05

Industry 2.35

EV/EBIT

65.49

Sector -27.46

Industry -3.67

P/EBITDA

9.39

Sector -32.50

Industry -53.91

P/EBIT

13.53

Sector -43.68

Industry -50.80

P/Total Assets

0.85

Sector 0.88

Industry 1.01

P/Net Current Assets

-4.69

Sector -27.11

Industry -10.74

P/Working Capital

8.67

Sector 2.78

Industry 2.87

EPS

3.75

Sector -0.70

Industry -0.60

BVPS

33.64

Sector 4.34

Industry 5.06

Efficiency

Gross Margin

31.32%

Sector 49.36%

Industry 50.85%

EBITDA Margin

7.63%

Sector -283.40%

Industry -56.64%

EBIT Margin

5.21%

Sector -164.84%

Industry -55.50%

Operating Margin

5.00%

Sector -19.73%

Industry -25.35%

Net Profit Margins

3.13%

Sector -24.22%

Industry -28.78%

Asset Turnover

0.30

Sector 0.13

Industry 0.15

Profitability

ROE

11.16%

Sector -24.32%

Industry -22.56%

ROA

3.74%

Sector -24.41%

Industry -24.19%

ROIC

6.68%

Sector -529.97%

Industry -94.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.32

Sector 1.90

Industry 2.01

Net Debt / EBITDA

8.12

Sector -4.96

Industry -2.23

Net Debt / EBIT

11.91

Sector -3.08

Industry -1.54

Net Debt / Equity

0.56

Sector -0.45

Industry -0.28

Gross Debt / Equity

0.60

Sector -0.74

Industry -0.81

Equity/Assets

0.34

Sector 0.46

Industry 0.47

Liabilities/Assets

0.59

Sector 0.49

Industry 0.52

Growth

5Y Revenue CAGR

1.87%

Sector -

Industry -

5Y Earnings CAGR

-8.38%

Sector -

Industry -

Fundamentals HSIC

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Henry Schein ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$86.23

Fair Value

$53.28

Upside

-38.22%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
HSIC Henry Schein Inc.	$86.23	27.28%	0.00%	22.64	2.53	11.16%	3.13%
ISRG Intuitive Surgical Inc.	$402.04	-9.45%	0.00%	44.01	7.60	17.26%	28.62%
ABT Abbott Laboratories	$101.51	-22.11%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$88.81	-3.46%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$44.04	-55.09%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$85.31	-27.36%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$222.83	-17.87%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$518.34	-17.35%	0.00%	35.48	25.07	70.67%	25.03%
COHR Coherent Inc.	$298.80	180.51%	0.00%	75.62	5.36	7.09%	11.19%
SYK Stryker Corp.	$274.78	-24.98%	1.26%	28.38	4.41	15.55%	14.43%
PHG Koninklijke Philips NV	$24.94	-5.39%	4.11%	18.19	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.30	-4.38%	0.00%	10.90	1.34	12.32%	20.69%
DXCM DexCom Inc.	$87.23	29.23%	0.00%	33.89	12.92	38.14%	20.12%
BDX Becton Dickinson and Company	$182.56	1.11%	2.34%	52.21	2.01	3.86%	6.30%
EW Edwards Lifesciences Corp.	$86.45	15.79%	0.00%	50.69	4.74	9.36%	15.41%
ALGN Align Technology Inc.	$147.64	15.18%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$26.88	-22.45%	2.80%	19.48	4.52	23.22%	9.83%
IRMD iRadimed Corporation	$86.02	23.89%	1.54%	45.76	10.37	22.66%	26.70%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HSIC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Henry Schein

Henry Schein Inc.

Average Investor10 user rating

4.0 (4 people)

United States

34 years

Founded: 1992

1995

Time since IPO - 31 years

19.000

Employees

Henry Schein Inc. (United States) is listed on the Nasdaq and has a market capitalization of $9.65 billion, with shareholders equity totaling $3.82 billion.

The company employs approximately 19.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Henry Schein Inc. reported $13.60 billion in revenue, generating net income of $426.00 million.

Key financial metrics include a P/E ratio of 22.64, a price-to-book (P/B) ratio of 2.53, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HSIC.

Market cap

$9.65 billion

Net worth

$3.82 billion

$3,817,000,000.00

Assets

$11.38 billion

$11,381,000,000.00

Total Shares Outstanding

113.45 million

113,451,000

Average Daily Trading Volume

$1.19 million

$1,192,970.00

Sector

Health

Industry

Medical Supplies and Equipment

HSIC

HSIC revenue and profits

Financial Results HSIC

DRAG THE FRAME TO SEE MORE DATA

HSIC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.20 20,08% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$271.17 --3,11% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$62.80 80,15% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$412.62 64,54% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$40.94 --6,56% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,162.62 61,48% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$432.22 3,81% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$144.84 19,41% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35